plerixafor has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binda, NS; Cecilia, FS; da Silva Junior, CA; da Silva, JF; de Castro Junior, CJ; Diniz, DM; do Nascimento Cordeiro, M; Ferreira, J; Gomez, MV; Pereira, EMR | 1 |
| Bae, JS; Jin, HK; Kim, BJ; Lee, JK; Schuchman, EH | 1 |
2 other study(ies) available for plerixafor and Diabetic Neuropathies
| Article | Year |
|---|---|
The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.
Topics: Analgesics; Animals; Benzylamines; Calcium; Calcium Channels; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heterocyclic Compounds; omega-Conotoxins; Rats; Rats, Wistar; Receptors, CXCR4; Spider Venoms | 2020 |
Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Diabetic Neuropathies; Endothelial Cells; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Peripheral Nervous System Diseases; Receptors, CXCR4; Sciatic Nerve; Stem Cells; Vasa Nervorum | 2013 |